Images List Premium Download Classic

Dermatitis

Dermatitis-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Compound of the avermectin family or of the milbemycin family for the treatment and/or ...
Galderma Sa
October 26, 2017 - N°20170304340

A method of treating and/or preventing atopic dermatitis is described. The method includes use of a compound of the avermectin family, possibly ivermectin, or a compound of the milbemycin family in a pharmaceutically acceptable carrier.
Treatment of atopic dermatitis with indigo naturalis or indigo producing plant extract
Galderma S.a.
October 12, 2017 - N°20170290804

A pharmaceutical or cosmetic composition comprising an indigo naturalis or indigo-producing plant extract for treating atopic dermatitis and any form of eczema, and a method of treating atopic dermatitis comprising administering a therapeutically effective amount of an indigo naturalis or indigo-producing plant extract to a subject in need thereof are described.
Predicting allergic reactions
Alcyomics Ltd
October 05, 2017 - N°20170285001

This present invention provides a method of predicting immunogenicity and hypersensitivity or allergic reactions to chemical compounds, therapeutics, cosmetics and other chemical compositions. The method uses an in vitro assay employing autologous blood derived cells and an autologous cultured skin biopsy and is of particular utility in the identification and prediction of skin sensitizers that cause allergic contact dermatitis.
Dermatitis Patent Pack
Download + patent application PDFs
Dermatitis Patent Applications
Download + Dermatitis-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dermatitis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Topical application of ivermectin for the treatment of dermatological conditions/afflictions
Galderma S.a.
October 05, 2017 - N°20170281664

Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
Topical application of ivermectin for the treatment of dermatological conditions/afflictions
Galderma S.a.
October 05, 2017 - N°20170281663

Dermatological conditions/afflictions such as rosacea, common acne, seborrheic dermatitis, perioral dermatitis, acneform rashes, transient acantholytic dermatosis, and acne necrotica miliaris, most notably rosacea, are treated by topically applying onto the affected skin area of an individual in need of such treatment, a topical pharmaceutical composition which comprises a thus effective amount of ivermectin.
Methods of treating skin disorders using anti-il-31ra antibodies
Zymogenetics, Inc.
September 28, 2017 - N°20170275369

The present invention relates to methods of treating patients suffering from contact dermatitis, drug induced delayed type cutaneous allergic reactions, toxic epidermal necrolysis, cutaneous t cell lymphoma, bullous pemphigoid, alopecia aereata, vitiligo, acne rosacea, prurigo nodularis, scleroderma, herpes simplex virus, or combination by administering an il-31ra antagonist.
Dermatitis Patent Pack
Download + patent application PDFs
Dermatitis Patent Applications
Download + Dermatitis-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dermatitis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Negative hydrogen ion intellegrnt filtration system for curing cancer, cardiovascular disease, diabetes, hypertension, nephrotic syndrome, ...
Mega Sun Biomedical Corp.
September 21, 2017 - N°20170267563

A negative hydrogen ion intelligent filtration system includes a housing; a filtering mechanism disposed in the housing and comprising a first filter, a second filter connected to the first filter, a third filter connected to second filter, a fourth filter connected to the third filter, a fifth filter connected to the fourth filter, a sixth filter connected to the fifth ...
Modulation of tissue transglutaminase activation in disease
The Board Of Trustees Of The Leland Stanford Junior University
September 21, 2017 - N°20170266198

Compositions and methods are provided for modulating the physiological activation of tissue transglutaminase (tg2); which methods can include inhibiting the activation of tg2 associated with enteric inflammatory disorders, which disorders may include celiac disease, irritable bowel syndrome, crohn's disease, dermatitis herpetiformis, and the like. In other embodiments of the invention, methods are provided for reducing undesirable paracellular transport in enteric ...
Methods of treating atopic dermatitis with il-31 monoclonal antibodies
Zymogenetics, Inc.
September 14, 2017 - N°20170260267

The present invention relates to methods of treating pruritic diseases, including but not limited to contact dermatitis, atopic dermatitis, drug induced delayed type cutaneous allergic reactions, toxic epidermal necrolysis, cutaneous t cell lymphoma, bullous pemphigoid, alopecia wereata, vitiligo, acne rosacea, prurigo nodularis, scleroderma, herpes simplex virus, or combination thereof by administering il-31 monoclonal antibodies. The invention further provides the hybridomas ...
Compositions comprising dihydroquercetin for use in methods for treating the effects associated with skin inflammatory ...
Bionoox Suisse Sa
August 31, 2017 - N°20170246141

A method of using a composition including dihydroquercetin, as well as optionally α-tocopherol and/or bisabolol, for treating the effects associated with skin inflammatory disorder, such as those associated with diseases characterized by inappropriate immune response, such as psoriasis, atopic dermatitis and/or urticaria. A process of manufacturing the composition is also described.
Chemical inhibitors of sebocyte function
Bionoox Suisse Sa
August 24, 2017 - N°20170240575

The present discovery pertains to the discovery of certain amphiphilic compounds that may be useful for the management of sebum secretion in subjects with acne, oily skin, or seborrheic dermatitis. These compounds are 1-dialkylphosphorylalkanes with the longest alkyl group being seven or more carbons. Preferably, a compound is dissolved in a dermatologically acceptable vehicle, and delivered to the skin in ...
4-methylsulfonyl-2-butenenitrile and its pharmaceutical use
Olatec Therapeutics Llc
August 17, 2017 - N°20170231944

The present invention is directed to a method of treating an inflammatory skin disease or disorder, such as dermatitis, psoriasis, acne, or rosacea. The method comprises administering to the subject 4-methylsulfonyl-2-butenenitrile, in an amount effective to reduce or eliminate the symptoms of the inflammatory skin disease or disorder. Topical administration and oral administration are preferred routes of administration.
Piperazine derivatives as liver x receptor modulators
Vitae Pharmaceuticals, Inc.
August 10, 2017 - N°20170226067

Provided are novel compounds of formula (i): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are liver x receptor modulators, and which are useful in the treatment of diseases and disorders associated with the liver x receptor. Also provided are the compounds of formula (i) and pharmaceutical compositions thereof for treating atherosclerosis, cardiovascular disease, alzheimer's disease, dermatitis, dyslipidemia, cancer ...
Dermatitis Patent Pack
Download + patent application PDFs
Dermatitis Patent Applications
Download + Dermatitis-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Dermatitis-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Treatment of atopic dermatitis and asthma using rna complexes that target il4ra, trpa1, or ...
Olix Pharmaceuticals, Inc.
August 03, 2017 - N°20170218376

In certain aspects, provided herein are rna complexes (e. G., asymmetric rna complexes, such as asirnas or cell penetrating asirnas) that inhibit il4rα, trpa1, and/or f2rl1 expression and are therefore useful for treating atopic dermatitis or asthma.
Azaindoline compounds as granzyme b inhibitors
Vida Therapeutics Inc.
August 03, 2017 - N°20170218014

Azaindoline compounds as granzyme b inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
Betalain compositions and methods therefor
Vdf Futureceuticals, Inc.
August 03, 2017 - N°20170216331

Contemplated compositions and methods employ betalains for treatment of various conditions, and especially osteoarthritis, sinusitis, contact dermatitis, acne, an allergic condition, reduced mental alertness, reduced physical strength, reduced physical endurance, and/or impaired mood.
Method for making herbal soap for alleviating atopic skin disease
Vdf Futureceuticals, Inc.
July 27, 2017 - N°20170209362

Provided is a method for making an herbal soap for alleviating atopic skin disease, the method comprising combining five main medicinal herbs consisting of kalopanacis cortex, amaranthus mangostanus, gardenia jasminoides, lonicerae flos and rumex japonicus houtt with four supplementary medicinal herbs consisting of glycyrrhiza uralensis fischer, mori cortex, phaseoli radiati semen and red ginseng, which serve to increase the efficacies ...
Composition comprising gpcr19 agonist as an active ingredient for preventing or treating allergic dermatitis
Shaperon Inc.
July 13, 2017 - N°20170196895

The present invention is about a pharmaceutical composition, an oral preparation, and an injection preparation containing a g protein-coupled receptor19 (gpcr19) agonist, specifically sodium taurodeoxycholate(hy2191) and its derivative, as an active ingredient for preventing or treating allergic skin diseases. The present invention is also about an external preparation and a cosmetic composition containing said pharmaceutical composition for preventing and ...
Ibs related testing and treatment
Shaperon Inc.
July 13, 2017 - N°20170196498

Methods and items useful at least therein are provided for ibs related testing and treatment. Disclosed is a patch useful in determining if one or more test materials can cause allergic contact dermatitis in a patient. A kit containing information on use and that may include such a patch and/or test material(s) is also disclosed. A method of ...
Methods of treating atopic dermatitis with il-31 monoclonal antibodies
Zymogenetics, Inc.
June 29, 2017 - N°20170182160

Novel compositions derived from antigen-binding sites of immunoglobulins having affinity for il-31 are provided. The compositions exhibit immunological binding properties of antibody molecules capable of binding specifically to a human il-31. Cdr regions derived from same or different immunoglobulin moieties are provided. Also provided are single chain polypeptides wherein vh and vl domains are attached. The sfv molecules can include ...
Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing ...
Druggability Technologies Ip Holdco Limited
June 15, 2017 - N°20170165237

The invention is directed to a stable complex with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound sirolimus or derivatives thereof, which is useful in the prophylaxis of organ rejection in patients receiving renal transplants, in the treatment of psoriasis, facial angiofibromas associated with tuberous sclerosis, fibrofolliculomas found in birt-hogg-dubé syndrome, chronic erosive ...
Loading